Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;11(3):431-48.
doi: 10.3111/13696990802306162.

Burden of Rotavirus Gastroenteritis and Potential Benefits of a Pentavalent Rotavirus Vaccination in Belgium

Affiliations

Burden of Rotavirus Gastroenteritis and Potential Benefits of a Pentavalent Rotavirus Vaccination in Belgium

Patrick Dhont et al. J Med Econ. .

Abstract

Objective and methods: A decision analytic model was built to assess the paediatric rotavirus gastroenteritis (RVGE) burden and potential benefits associated with the introduction of RotaTeq (pentavalent rotavirus vaccine) in Belgium.

Results: In the absence of a rotavirus (RV) immunisation programme, paediatric RVGE was estimated to account for about 5,860 hospitalisations, 1,720 cases of nosocomial infections, 9,410 cases treated by general practitioners/paediatricians (GP/P) and 10,790 cases not seeking medical care for a birth cohort followed up to 5 years of age. Paediatric RVGE was estimated to cost about euro9.0 million from the Belgian healthcare provider perspective and euro15.3 million to society. Given a 90% RV vaccination coverage rate, the pentavalent RV vaccine would have a high impact on RV burden by preventing more than 4,850 hospitalisations, 995 cases of nosocomial infections, 7,145 cases treated by GP/P and 8,190 cases not seeking medical care, and reduce RVGE costs by euro7.1 million from the Belgian healthcare provider perspective and euro12.0 million to society.

Similar articles

See all similar articles

Cited by 2 articles

LinkOut - more resources

Feedback